LABTRACE.ORG BETA LIVE
240 source polls this hour 39 310 articles collected last article 3m ago 634 events on 2+ sources 0 embeddings/h feed queue 0 lag 382.0s
← all events
LT-014164 / first seen 2026-08-27 17:23 / last activity 14d ago solid / under-covered

Dupilumab treatment improves linear growth and bone biomarkers in children with atopic dermatitis: Post hoc analysis of a phase 3 randomized, placebo-controlled clinical trial and an open-label extension study

measurement

heat
13 / 100 (raw 0.3)
velocity
0.0 independent sources per hour
solidity
80 / 100
sources
1 total, 1 independent
domain span
1 domain covered it

primary source

title
Dupilumab treatment improves linear growth and bone biomarkers in children with atopic dermatitis: Post hoc analysis of a phase 3 randomized, placebo-controlled clinical trial and an open-label extension study
venue
status
peer-reviewed
doi
10.1016/j.jaad.2026.07.006
published
2026-07-01

media coverage / 1 outlets